Lifevantage (LFVN) EPS (Weighted Average and Diluted) (2016 - 2025)
Lifevantage (LFVN) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $0.02 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 89.47% year-over-year to $0.02, compared with a TTM value of $0.61 through Dec 2025, up 8.93%, and an annual FY2025 reading of $0.75, up 226.09% over the prior year.
- EPS (Weighted Average and Diluted) was $0.02 for Q4 2025 at Lifevantage, down from $0.17 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.35 in Q2 2021 and bottomed at -$0.11 in Q2 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.1, with a median of $0.11 recorded in 2021.
- The sharpest move saw EPS (Weighted Average and Diluted) plummeted 900.0% in 2022, then skyrocketed 480.0% in 2024.
- Year by year, EPS (Weighted Average and Diluted) stood at $0.01 in 2021, then tumbled by 900.0% to -$0.08 in 2022, then soared by 37.5% to -$0.05 in 2023, then soared by 480.0% to $0.19 in 2024, then tumbled by 89.47% to $0.02 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for LFVN at $0.02 in Q4 2025, $0.17 in Q3 2025, and $0.15 in Q2 2025.